Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-22, Stock:JNJ, The news for the past five days is as follows:
2019-05-15: NEWS1: Johnson & Johnson Unveils 5-Year Growth Plan for Pharmaceutical Business.NEWS2: Johnson & Johnson to submit applications for at least 10 new drugs by 2023.NEWS3: Health Care Sector Update for 05/15/2019: IMGN, A, ACBI, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 05/15/2019: IMGN, A, ACBI, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS6: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS7: J&J analyst day drives focus on drug business as talc baby powder comes under fire.NEWS8: J&J analyst day tries to steer focus to drug business as talc baby powder comes under fire.NEWS9: Johnson & Johnson CEO Alex Gorsky on what's in the pipeline, growth drivers and talc lawsuit.NEWS10: Johnson & Johnson details a new five year plan.NEWS11: Bull of the Day: Penumbra (PEN).NEWS12: Bull of the Day: Penumbra (PEN).NEWS13: Johnson & Johnson to submit applications for at least 10 new drugs by 2023.NEWS14: Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review.NEWS15: Bull of the Day: Penumbra (PEN).NEWS16: 8 Stocks That Can Prosper Amid the Trade War.
2019-05-16: NEWS1: Did Geron's Big Announcement Just Go Unnoticed?.NEWS2: Did Geron's Big Announcement Just Go Unnoticed?.NEWS3: Did Geron&apos;s Big Announcement Just Go Unnoticed?.NEWS4: Johnson & Johnson Is a Defensive Stock. Now There’s Hope for Growth..NEWS5: XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF.NEWS6: XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF.NEWS7: Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report?.NEWS8: Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report?.NEWS9: Alert: This Life-Changing 7% Dividend Is Vanishing Fast.NEWS10: Alert: This Life-Changing 7% Dividend Is Vanishing Fast.NEWS11: Johnson & Johnson Analysts Laud Accelerating Pharma Business.NEWS12: Health Care Sector Update for 05/16/2019: AGIO, MGNX, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 05/16/2019: AGIO, MGNX, NTEC, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Why Is Johnson & Johnson (JNJ) Down 1.2% Since Last Earnings Report?.NEWS15: Alex Gibney joins Influencers with Andy Serwer.
2019-05-17: NEWS1: Trade war trades: 6 stocks.NEWS2: Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout.NEWS3: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - Sources.NEWS4: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources.NEWS5: Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources.NEWS6: U.S. FDA labels J&J surgical staplers' recall as severest.NEWS7: U.S. FDA labels J&J surgical staplers' recall as severest.NEWS8: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS9: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS10: Insiders Buy the Holdings of DLN ETF.NEWS11: Insiders Buy the Holdings of DLN ETF.NEWS12: FDA issues recall of J&J unit Ethicon's surgical staplers.NEWS13: Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Your first trade for Friday, May 17.NEWS16: Johnson & Johnson to Participate in Bernstein's 35th Annual Strategic Decisions Conference.NEWS17: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.
2019-05-20: NEWS1: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS2: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS3: ARWR: ARO-AAT Ph 2/3 Detailed, Could Serve as FDA Pivotal Study. Continued Broad-Based Pipeline Progress.NEWS4: Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs.NEWS5: Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices.NEWS6: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS7: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS8: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS9: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS10: Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN.NEWS12: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS13: AbbVie's Brain Cancer Candidate Fails in Phase III Study.NEWS14: After J&J sale, Cambridge investor sets sights on $175M raise for new medtech VC firm.
2019-05-21: NEWS1: West Chester company to eliminate 76 jobs.NEWS2: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS3: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix.NEWS5: 2 Stocks to be Wary Of (And One Defensive Play).

Answer: Rise